Understanding Patent Office Actions: A Guide to Common Rejections

Receiving a patent Office Action is not a setback — it is a normal, expected part of the prosecution process. The vast majority of patent applications receive at least one Office Action before being granted. Examiners are trained to reject first and grant only when they are satisfied that the claims are novel, non-obvious, and properly supported. Understanding what each type of rejection means, why it was issued, and how to respond strategically is the difference between a strong granted patent and a weak one — or no patent at all.

This guide explains the most common types of Office Actions issued by major patent offices around the world, what each means in plain language, and how inventors and their attorneys approach responses.

What Is an Office Action?

An Office Action (also called an Examination Report, Office Communication, or Written Opinion depending on the jurisdiction) is a formal document issued by a patent examiner that raises objections or rejections to a patent application. The applicant has a set period to respond — typically 3–6 months, often extendable — and must address every issue raised.

Office Actions are not final decisions. They open a dialogue between the applicant and the examiner. The applicant can:

• Argue that the examiner's rejection is wrong (traverse the rejection)
• Amend the claims to address the rejection
• Do both simultaneously

This back-and-forth — called prosecution — continues until the examiner is satisfied (and issues an allowance) or until the applicant exhausts their response options (and faces a final rejection, with appeal options remaining).

What happens if you do not respond? If you miss the response deadline without requesting an extension, the application is deemed abandoned. In most jurisdictions, abandonment is reversible within a limited window; after that window, the application is permanently abandoned. Set calendar reminders for every Office Action deadline immediately upon receipt.

Types of Office Action by Jurisdiction

Different patent offices use different terminology:

Despite different names, the substantive types of rejection are broadly similar across all major jurisdictions — they derive from the same underlying patent law principles.

Rejection Type 1: Lack of Novelty (Anticipation)

What it means: The examiner has found a single prior art document that discloses every element of your claim. Your claim is "anticipated" — the invention was already known before your filing date.

In the examiner's language:

• USPTO: "Claims X-Y are rejected under 35 USC §102 as being anticipated by [reference]"
• EPO: "Claims X-Y lack novelty within the meaning of Article 54 EPC in view of document D1"
• CNIPA: "Claims X-Y lack novelty under Article 22(2) of the Patent Law"
• JPO: "Claims X-Y do not fulfil the requirements of Article 29(1) of the Patent Act"

Why it happens: The prior art reference describes every element of your claim — not just the general concept, but each specific element as you have claimed it. Even if the prior art reference was not aimed at your application, if it discloses the same combination of elements, the claim lacks novelty.

How to respond:

Amend the claims to add an element that is not in the cited reference. The amended claim must be supported by your specification — you cannot add new elements that were not disclosed. This is the most common response to anticipation rejections.

Argue that the reference does not disclose all elements. Review the reference carefully. Sometimes examiners misread claims or cite a reference that does not actually disclose a key element. If you can demonstrate that a specific element of your claim is not present in the reference, argue this clearly.

Distinguish on effective date. If the cited reference has a filing or publication date that post-dates your priority date, it cannot be used as prior art against you. Check dates carefully — examiners occasionally cite references that are not actually prior art because of their date.

Rejection Type 2: Obviousness (Lack of Inventive Step)

What it means: No single reference discloses every element of your claim, but a combination of references makes your claim obvious — a skilled person in the field would have found it obvious to combine the references to arrive at your invention.

In the examiner's language:

• USPTO: "Claims X-Y are rejected under 35 USC §103 as being unpatentable over [reference 1] in view of [reference 2]"
• EPO: "The subject-matter of claims X-Y does not involve an inventive step (Article 56 EPC) having regard to the disclosure of D1 combined with D2"
• CNIPA: "Claims X-Y lack inventive step under Article 22(3) of the Patent Law"
• JPO: "Claims X-Y do not fulfil the requirements of Article 29(2) of the Patent Act (inventive step)"

Obviousness is the most common and most contested type of rejection. Unlike anticipation — which is a binary factual question — obviousness involves a judgment call, which means it is more susceptible to argument.

Why it happens: The examiner believes that combining two or more existing documents would lead a skilled person to your invention. This requires: (1) each element of your claim is present in the cited art, and (2) there was motivation to combine the references.

How to respond:

Argue there was no motivation to combine. The examiner must articulate why a skilled person would have been motivated to combine the cited references. If the references are from different fields, address different problems, or use incompatible approaches, you can argue that no skilled person would have combined them.

Argue unexpected results or synergistic effects. If your invention produces results that were unexpected given the prior art — better performance than the sum of parts would predict — this is evidence of non-obviousness. Provide experimental data.

Argue secondary considerations (objective indicia of non-obviousness):

• Commercial success: If your invention has been commercially successful, this suggests it was not obvious (otherwise someone would have done it earlier)
• Long-felt but unsolved need: If the problem existed for years without a solution until your invention, this suggests non-obviousness
• Failure of others: If others tried and failed to solve the same problem
• Copying by competitors: If competitors have copied your invention, they evidently did not find it obvious

Amend claims to add non-obvious distinguishing features. Add an element from your specification that is present in neither cited reference.

The EPO Problem-Solution Approach: The EPO uses a structured "problem-solution approach" for assessing inventive step. The examiner identifies the closest prior art, determines the technical differences between that document and your claim, formulates an "objective technical problem" solved by those differences, and asks whether the solution would have been obvious to a skilled person. Responses to EPO obviousness rejections should engage with this framework directly.

Rejection Type 3: Indefiniteness

What it means: A claim or claim term is not sufficiently clear and precise. The boundaries of the claimed invention are unclear — it is not possible to determine from the claim language what falls within and outside the claim.

In the examiner's language:

• USPTO: "Claims X-Y are rejected under 35 USC §112(b) as being indefinite for failing to particularly point out and distinctly claim the subject matter..."
• EPO: "Claims X-Y lack clarity within the meaning of Article 84 EPC"
• CNIPA: "Claims X-Y do not meet the clarity requirements of Rule 20 of the Implementing Regulations"

Common causes of indefiniteness:

Relative terms without reference points: "A large housing" — large compared to what? "Approximately 50°C" without specification of the acceptable range.

Functional language without structural support: "A means for achieving high efficiency" without describing what constitutes high efficiency or how it is measured.

Antecedent basis errors: "The valve" is referenced in a claim but "a valve" was never introduced. Or "the first element" but only "an element" was introduced, with no "second element" to establish a "first."

Inconsistency between claim and specification: The claim uses terminology that differs from the specification, making it unclear which meaning controls.

How to respond:

Amend the indefinite term to be more specific: "large" becomes "having a diameter greater than 50mm," "approximately 50°C" becomes "between 45°C and 55°C."

Add antecedent basis: Amend the claim to introduce each element on its first reference ("a valve") before subsequent references ("the valve").

Argue the term has a well-understood meaning: If the term is standard in the art and has a universally understood meaning among skilled practitioners, argue this with supporting evidence (technical dictionaries, textbooks, prior patents using the same term in the same way).

Rejection Type 4: Lack of Written Description / Insufficient Disclosure

What it means: The specification does not adequately demonstrate that the inventor had possession of the claimed invention at the time of filing (written description), or does not enable a skilled person to make and use the invention without undue experimentation (enablement).

In the examiner's language:

• USPTO: "Claims X-Y are rejected under 35 USC §112(a) as failing to comply with the written description requirement" or "...enablement requirement"
• EPO: "The application does not disclose the invention in a manner sufficiently clear and complete (Article 83 EPC / Rule 42 EPC)"
• CNIPA: "The specification fails to meet the disclosure sufficiency requirements of Article 26 of the Patent Law"

Common causes:

Genus-species mismatch: Claiming a broad class of compounds when only a few specific examples are described, with no basis for concluding the whole class works.

New matter in claims: Claims were amended during prosecution to cover something not described in the original specification.

Missing key steps or parameters: A method claim includes a step for which the specification provides no guidance on how to perform it.

Unpredictable fields: In biotechnology and chemistry, where results are less predictable than in mechanical engineering, examiners require more examples to support broad claims.

How to respond:

Point to specific passages in the specification that demonstrate written description support or enablement for the challenged claims.

Amend claims to match the described embodiments — narrowing to the specific examples provided.

Provide a declaration from the inventor or an expert demonstrating that the specification enables the claimed invention and that a skilled person could carry it out without undue experimentation.

Rejection Type 5: Non-Patentable Subject Matter

What it means: The claimed invention falls into a category that is excluded from patent protection in the relevant jurisdiction — abstract ideas, laws of nature, natural phenomena, methods of treatment, software without technical character, business methods, and so on.

In the examiner's language:

• USPTO: "Claims X-Y are rejected under 35 USC §101 as directed to patent-ineligible subject matter"
• EPO: "Claims X-Y relate to excluded subject matter (Article 52 EPC) / a method for treatment of the human body (Article 53(c) EPC)"
• CNIPA: "Claims X-Y do not constitute a technical solution (Article 2 of the Patent Law)"

Common situations by jurisdiction:

US (§101): Abstract ideas implemented in software without a "practical application" transforming the abstract idea into a patent-eligible invention. Mathematical concepts, mental processes, methods of organising human activity — unless tied to a specific machine or transformation. Post-Alice (Alice Corp. v. CLS Bank, 2014) rejections are extremely common for software-related inventions.

EPO (Article 52): Pure business methods, mathematical methods, and computer programs "as such." The EPO key question is whether the claim has "technical character" — does it produce a technical effect? Software that produces a technical effect beyond the normal physical interactions of running a program may be patentable.

EPO (Article 53(c)): Methods of treatment of the human body by surgery or therapy, and diagnostic methods — not patentable as method claims. Product claims and purpose-limited product claims (Swiss-type second medical use) are the workaround.

China: Pure software, business rules, mathematical methods, and "mental activities" are not patentable. The claim must describe a "technical solution" to a "technical problem" producing a "technical effect."

India: Computer programs per se, business methods, mathematical methods, algorithms, methods of treatment of humans or animals, and discoveries are excluded from patentability.

How to respond:

Amend claims to emphasise technical character: Add specific technical features. For software claims, tie the method to specific hardware, data structures, or measurable technical outputs. For abstract idea rejections, frame the claim around the specific technical improvement achieved.

Argue the claim is not directed to excluded subject matter: Argue that the claim as a whole, viewed in light of the specification, amounts to significantly more than the abstract idea or excluded category.

Convert to allowable form: In jurisdictions where method of treatment is excluded, convert to a product (device, composition) claim or a Swiss-type second medical use claim.

Rejection Type 6: Formal and Procedural Objections

Not all Office Action issues are substantive rejections. Many involve formal requirements that are straightforward to address:

Drawings objections: Non-compliant line weights, missing reference numerals, inconsistent numbering across figures, drawings not matching the description. Corrected drawings are submitted to overcome these.

Abstract too long / too short: Exceeds word limit or is inadequate. Revise to comply with the office's requirements.

Missing parts: Application filed without required sections, fees not paid, sequence listings missing. Generally addressed by submitting the missing material.

Translation issues: In non-English prosecution, translation errors create inconsistencies between the original and the national phase documents. Usually correctable.

Unity of invention: The application claims two or more inventions that are not linked by a single general inventive concept. The office requires the applicant to elect one invention to pursue and to pay additional fees to prosecute the others (in divisional applications). Common in applications with multiple independent claims.

Responding to Office Actions: Strategic Principles

Read Every Cited Reference Carefully

Do not assume the examiner has correctly characterised the reference. Read the primary reference fully — and in its original language if possible (using Google Patents' translation). Errors in the examiner's reading of references are not uncommon and can be the basis for a persuasive response.

Match Your Response to the Rejection

A well-structured response:

1. Acknowledges the Office Action and recites the claims under rejection
2. For each rejection, addresses it directly — arguing against it, amending the claim, or both
3. States clearly why the claims as amended (or as originally filed) are allowable
4. Concludes with a request for reconsideration and allowance

Avoid generic responses that do not engage specifically with the examiner's arguments. Examiners respond better to arguments that engage directly with their reasoning.

Consider the Interview Option

Most patent offices allow applicants to request an interview with the examiner — a telephone call, video call, or in-person meeting — to discuss the Office Action before or alongside a formal written response. Interviews can be extremely effective. Examiners are human; a direct conversation often leads to more efficient resolution than lengthy written exchanges. Ask your attorney whether an examiner interview would be beneficial.

Preserve the Breadth of Your Claims

Every amendment that narrows a claim limits its future scope. Prosecution history estoppel — the principle that statements and amendments made during prosecution can limit claim scope in court — means that how you respond to Office Actions determines how broadly your patent will be interpreted in litigation. Where possible, argue against rejections rather than simply amending claims. When amendments are necessary, make them as narrow as needed and no narrower.

Response Time Limits by Major Office

Missing a response deadline without an extension causes the application to go abandoned. In most offices, a petition to revive is possible within a limited period but costs additional fees and requires showing that the delay was unintentional.

Final Office Actions and What Follows

The Final Office Action (US)

In the US, after the first non-final Office Action and the applicant's response, the examiner may issue a Final Office Action. "Final" does not mean the end — but it does restrict the applicant's options:

After a Final Office Action, the applicant may:

• File a Request for Continued Examination (RCE): Pay a fee to reopen prosecution, getting another non-final Office Action. The most common approach.
• File an Appeal: Appeal the examiner's rejection to the Patent Trial and Appeal Board (PTAB). More time-consuming and expensive but appropriate when the examiner is wrong on the law or facts.
• File a continuation application: File a new application claiming priority to the original, with modified claims. Keeps the patent family alive while shifting prosecution to fresh claims.
• Allow the application to go abandoned: If the commercial case no longer justifies continued prosecution.

EPO Oral Proceedings

At the EPO, after exchanges of written communications, the applicant may request (or the examiner may summon) oral proceedings — a hearing before the examiner or, in appeal cases, before a Board of Appeal. Oral proceedings are a hallmark of EPO practice and allow the applicant and examiner to resolve issues face-to-face. Many applications are allowed at or shortly after oral proceedings.

Appeals in Other Jurisdictions

Most major patent offices have an appeal mechanism:

• PTAB (US) — appeals from examiner decisions; also handles post-grant IPR and PGR proceedings
• EPO Board of Appeal — independent from the examining division; reviews examination decisions
• CNIPA Review Board — handles Chinese patent appeal proceedings
• JPO Appeal Board — reviews JPO examination decisions
• KIPO Intellectual Property Trial and Appeal Board (IPTAB) — reviews KIPO decisions
• IPAB (India) — now reconstituted under the High Courts following 2021 reform

The Hard Truth About Office Actions

First-time inventors often interpret an Office Action as the examiner telling them their invention is not patentable. It usually is not. An Office Action is, in most cases, the examiner telling you that your claims as currently written are not allowable — and that is a very different thing.

Examiners are measured on production metrics. They process hundreds of applications per year. Their incentive is to resolve cases efficiently. A clearly written response that addresses every objection directly, proposes specific amendments, and explains concisely why the amended claims are patentable makes the examiner's job easier — and significantly increases the likelihood of allowance.

Conversely, the worst thing an inventor can do is write a long, argumentative, combative response that challenges the examiner's competence or expertise. Examiners are civil servants, not adversaries. Treating them as allies who need the right information to allow your claims produces dramatically better outcomes than treating them as obstacles.

Three practical principles for responding to Office Actions:

First, respond to every single point raised. Ignoring even one issue — even one you think is frivolous — gives the examiner grounds to maintain the rejection. Address every objection explicitly, even if the response is "this objection is traversed because..."

Second, use examiner interviews. In the US, you can request a telephonic or video interview with the examiner before filing a formal response. This is underused and enormously valuable. A 20-minute conversation often resolves ambiguities that would otherwise produce another round of rejection and response. The EPO's oral proceedings serve a similar function. Use them.

Third, know when to stop. If you have responded twice, amended claims significantly, and the examiner is still rejecting on the same grounds — the examiner may be right. At that point, the options are appeal (which can succeed), filing a continuation with different claims, or accepting that meaningful protection on this particular claim set is not available. Continuing to argue the same points produces the same outcome.

Sources

1. USPTO MPEP - Office Actions — US procedures for examination, rejections, and applicant responses
2. EPO - Guidelines for Examination — European examination procedures and objection types
3. 35 U.S.C. - Patent Law — US patent statutes including sections 101, 102, 103, and 112 rejection bases
4. CNIPA — China's patent examination procedures and office action requirements
5. European Patent Convention (EPC) — European patent rules on examination and opposition procedures